(Q40799596)

23 September 2017

title

Surveying physicians to determine the minimal important difference: implications for sample-size calculation (English)

1 reference

23 September 2017

3

1 reference

23 September 2017

van Walraven C

1

1 reference

23 September 2017

Mahon JL

series ordinal

2

1 reference

23 September 2017

Bohm C

series ordinal

4

1 reference

23 September 2017

Laupacis A

series ordinal

5

1 reference

23 September 2017

publication date

1 August 1999

1 reference

Journal of Clinical Epidemiology

23 September 2017

published in

1 reference

23 September 2017

volume

52

1 reference

23 September 2017

issue

8

1 reference

23 September 2017

page(s)

717-723

1 reference

Assessing the minimal important difference in symptoms: a comparison of two techniques.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

Absolutely relative: how research results are summarized can affect treatment decisions

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

Prescribing propensity: influence of life-expectancy gains and drug costs

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients' acceptance of treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

The framing effect of relative and absolute risk

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

The Value of Ultrasonography in the Diagnosis of Abdominal Aortic Aneurysm

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

Factors influencing enlargement rate of small abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

Expansion of aortic aneurysms is reduced by propranolol in a hypertensive rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

An assessment of clinically useful measures of the consequences of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

Can there be a more patient-centred approach to determining clinically important effect sizes for randomized treatment trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

Patients' views on the least acceptable increase in survival with zidovudine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

Indexes and boundaries for "quantitative significance" in statistical decisions

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900050-5

7 January 2021

10.1016/S0895-4356(99)00050-5

Identifiers

DOI

1 reference

23 September 2017

1 reference